Evidence map›Paper›PMID 37045681›Full record

ArticleVaccine2023

Pediatricians' perceptions, practices, and barriers regarding COVID-19 vaccine for children: A cross-sectional survey in Ontario, Canada.

Yamna Ali, Pierre-Philippe Piche-Renaud, Elahe Karimi-Shahrbabak, Daniel S Farrar, Sarah Abu Fadaleh, Sharon Burey, Shaun K Morris

Open access · hybridAbstract read
In one paragraph

Article in Vaccine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Tunisian Pediatricians' Attitudes and Practices Toward COVID-19 Immunization and Other Vaccines.International journal of environmental research and public health · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yamna AliDivision of Paediatric Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada; Department of Paediatrics, Temerty Faculty of Medicine, University of Toronto, 555 University Avenue, Toronto, ON M5G 1X8, Canada. Electronic address: Yamna.ali@sickkids.ca.
Pierre-Philippe Piche-RenaudDepartment of Paediatrics, Temerty Faculty of Medicine, University of Toronto, 555 University Avenue, Toronto, ON M5G 1X8, Canada; Division of Infectious Diseases, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada. Electronic address: Pp.piche-renaud@sickkids.ca.
Elahe Karimi-ShahrbabakCentre for Global Child Health and Child Health Evaluative Sciences, The Hospital for Sick Children, 686 Bay Street, Toronto, ON M5G 0A4, Canada. Electronic address: Elahe.karimishahrbabak@sickkids.ca.
Daniel S FarrarCentre for Global Child Health and Child Health Evaluative Sciences, The Hospital for Sick Children, 686 Bay Street, Toronto, ON M5G 0A4, Canada. Electronic address: Daniel.farrar@sickkids.ca.
Sarah Abu FadalehCentre for Global Child Health and Child Health Evaluative Sciences, The Hospital for Sick Children, 686 Bay Street, Toronto, ON M5G 0A4, Canada. Electronic address: Sarah.abufadaleh@sickkids.ca.
Sharon BureyDepartment of Paediatrics, Schulich School of Medicine & Dentistry, Western University, 800 Commissioners Road E, London, ON N6A 5W9, Canada; Paediatricians Alliance of Ontario, ON, Canada. Electronic address: Sburey@uwo.ca.
Shaun K MorrisDepartment of Paediatrics, Temerty Faculty of Medicine, University of Toronto, 555 University Avenue, Toronto, ON M5G 1X8, Canada; Division of Infectious Diseases, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada; Centre for Global Child Health and Child Health Evaluative Sciences, The Hospital for Sick Children, 686 Bay Street, Toronto, ON M5G 0A4, Canada; Centre for Vaccine Preventable Diseases and Clinical Public Health, Dalla Lana School of Public Health, 155 College Street, Toronto, ON M5T 3M7, Canada. Electronic address: shaun.morris@sickkids.ca.
Hospital for Sick Children · CAUniversity of Toronto · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSARS-CoV-2 vaccination of all age-eligible populations is an important part of the COVID-19 pandemic response. In Ontario, vaccination coverage in 5-to-11-year-old children has remained lower than in other age groups. We sought to understand pediatricians' perception, practices, and barriers to SARS-CoV-2 vaccination in children, particularly children aged 5-to-11 years, to inform interventions and promote capacity of pediatricians as vaccinators and vaccination promoters.

methodsThis is a descriptive, cross-sectional study consisting of an online self-administered questionnaire distributed to 1,313 pediatricians in Ontario. Descriptive statistics, including Chi-square or Fisher's exact tests, were performed.

resultsIn total, 152 Pediatricians responded (11.6% response rate), from February 17, 2022 to March 17, 2022. 78% of respondents were general pediatricians and 22% were pediatric subspecialists. Median years of practice was 17 (8-31), with 68% female, 32% male. Most pediatricians thought it was unlikely that children aged 5-to-11 years would become seriously ill from acute COVID-19 caused by Delta (66%) or Omicron (80%). 92% were very likely to recommend the COVID-19 vaccine for children aged 5-to-11 years. COVID-19 vaccine was perceived as safe, with higher safety perception in children aged 5-to-11 compared to 12-to-17 years (p < 0.0001). COVID-19 vaccines were thought to be effective in reducing hospitalization or severe illness, and reducing SARS-CoV-2 infection, with higher perceived effectiveness against Delta compared to Omicron (p < 0.0001). 97% felt confident counselling caregivers of children aged 5-to-11 years on the COVID-19 vaccine. Few pediatricians did not feel confident in accessing resources for health professionals (6%) or for patients/caregivers (12%).

conclusionsMost surveyed pediatricians were very likely to recommend COVID-19 vaccination for children aged 5-to-11-years, perceived COVID-19 vaccines as safe and effective, and felt confident in their COVID-19 vaccine counselling for children aged 5-to-11 years. However, there remains areas for further training and capacity development.

Indexed as

COVID-19COVID-19 VaccinesChildChild, PreschoolCross-Sectional StudiesFemaleHumansMaleOntarioPandemicsPediatriciansSARS-CoV-2VaccinationCOVID-19 VaccinesCOVID-19PediatricianPediatricsSARS-CoV-2SurveyVaccine

Identifiers

PMID37045681
PMCPMC10067459
OpenAlexW4362582260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.